The Management Impact of 68gallium-Tris(hydroxypyridinone) Prostate-Specific Membrane Antigen (68Ga-THP-Psma) PET-CT Imaging for High-Risk and Biochemically Recurrent Prostate Cancer
European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-019-04643-7
Full Text
Open PDFAbstract
Available in full text
Date
December 23, 2019
Authors
Publisher
Springer Science and Business Media LLC